Skip to Content
Merck
CN

Key Documents

View All Documentation

821-500

Astrocyte Growth Medium (500 ml)

Synonym(s):

Astrocyte Medium

Sign In to View Organizational & Contract Pricing.

Select a Size

Change View

About This Item

NACRES:
NA.71
UNSPSC Code:
12352207
Technical Service
Need help? Our team of experienced scientists is here for you.
Let Us Assist

form

liquid

shelf life

6 mo.

manufacturer/tradename

Cell Applications, Inc

shipped in

wet ice

storage temp.

2-8°C

General description

Astrocyte growth medium is an all-in-one ready-to-use media, which is optimized for the characteristics and requirements unique to human astrocytes.

Application

Astrocyte growth medium (500 ml) has been used to culture and maintain normal human astrocytes.

Preparation Note

contained in protocol

Analysis Note

Each lot was tested for the ability to support plating, spreading and proliferation

Storage Class

12 - Non Combustible Liquids

wgk

WGK 1

flash_point_f

Not applicable

flash_point_c

Not applicable

Regulatory Information

新产品

This item has

Choose from one of the most recent versions:

Certificates of Analysis (COA)

Lot/Batch Number

It looks like we've run into a problem, but you can still download Certificates of Analysis from our Documents section.

If you need assistance, please contact Customer Support

Already Own This Product?

Find documentation for the products that you have recently purchased in the Document Library.

Visit the Document Library

Protocols

Human Astrocytes (HA) Culture Protocol

Store the cryovials in a liquid nitrogen storage tank immediately upon arrival.

Yi-Ting Lin et al.
Journal of clinical medicine, 8(2) (2019-02-16)
Uremic toxins accumulated in chronic kidney disease (CKD) increases the risk of cognitive impairment. Indoxyl sulfate (IS) is a well-known protein-bound uremic toxin that is correlated with several systemic diseases, but no studies on human brain cells are available. We
Jiaxin Sun et al.
Scientific reports, 10(1), 13899-13899 (2020-08-19)
Metabolic reprogramming in cancer cells, vs. non-cancer cells, elevates levels of reactive oxygen species (ROS) leading to higher oxidative stress. The elevated ROS levels suggest a vulnerability to excess prooxidant loads leading to selective cell death, a therapeutically exploitable difference.
Iris Maria Forte et al.
International journal of oncology, 54(6), 2189-2199 (2019-05-14)
Glioblastoma (GB) is the most common and aggressive malignant tumor of the central nervous system. Despite current intensive treatment regimens, consisting of surgical resection followed by radiotherapy with concomitant and adjuvant temozolomide (TMZ) chemotherapy, the prognosis of patients with GB remains

Global Trade Item Number

SKUGTIN
821-50004061833004937